These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24413312)

  • 21. Reducing mortality from HIV infection and tuberculosis.
    Koole O; Colebunders R
    Lancet Infect Dis; 2011 Jul; 11(7):494-5. PubMed ID: 21514235
    [No Abstract]   [Full Text] [Related]  

  • 22. Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test.
    Gras L; van Sighem A; Bezemer D; Smit C; Wit F; de Wolf F;
    AIDS; 2011 Mar; 25(6):813-8. PubMed ID: 21330906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiretroviral therapy suppression: already a new strategy?].
    Viciana Fernández P; Mata Alcázar-Caballero R; López Cortés LF
    Farm Hosp; 2004; 28(6 Suppl 1):85-91. PubMed ID: 15649120
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortality.
    Wyles DL
    Clin Infect Dis; 2008 Dec; 47(11):1476-8. PubMed ID: 18959495
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial Commentary: Scaling Up Antiretroviral Therapy in Africa: Are We There Yet?
    Manasa J; Katzenstein D
    Clin Infect Dis; 2016 Feb; 62(4):519-20. PubMed ID: 26561533
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiretroviral drug treatment of CNS HIV-1 infection.
    Yilmaz A; Price RW; Gisslén M
    J Antimicrob Chemother; 2012 Feb; 67(2):299-311. PubMed ID: 22160207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How have guidelines on when to start antiretroviral therapy affected survival of people living with HIV infection?
    Rodger AJ; Sabin CA
    Curr Opin HIV AIDS; 2016 Sep; 11(5):487-491. PubMed ID: 27465878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of a 24 month follow-up of HIV patients without change in their primary antiretroviral therapy].
    Marcos Sánchez F; Marcos Sánchez F; Albo Castaño I; Arbol Linde F; Viana Alonso A
    An Med Interna; 2003 Nov; 20(11):599. PubMed ID: 14624662
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiretroviral therapy at the end of life: the experience of an academic HIV clinic.
    Ruiz M; Armstrong M; Reske T; Cefalu C; Anwar D
    Am J Hosp Palliat Care; 2014 Aug; 31(5):475-9. PubMed ID: 23838449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E; De Silvestri A; Boschi A; Tinelli C
    AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stopping antiretroviral therapy: role for therapeutic drug monitoring.
    Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P
    AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237
    [No Abstract]   [Full Text] [Related]  

  • 32. Economics of monitoring antiretroviral therapy.
    Mermin J; Granich R
    Lancet Infect Dis; 2013 Jul; 13(7):560-1. PubMed ID: 23602085
    [No Abstract]   [Full Text] [Related]  

  • 33. Haiti trial supports starting antiretroviral therapy earlier.
    AIDS Patient Care STDS; 2009 Jul; 23(7):577. PubMed ID: 19621995
    [No Abstract]   [Full Text] [Related]  

  • 34. Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts.
    Abioye AI; Soipe AI; Salako AA; Odesanya MO; Okuneye TA; Abioye AI; Ismail KA; Omotayo MO
    AIDS Care; 2015; 27(12):1468-86. PubMed ID: 26695132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with discontinuation of anti-retroviral therapy among adults living with HIV/AIDS in Ethiopia: a systematic review protocol.
    Gesesew HA; Mwanri L; Ward P; Woldemicahel K; Feyissa GT
    JBI Database System Rev Implement Rep; 2016 Feb; 14(2):26-37. PubMed ID: 27536791
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiretroviral Therapy for Nevirapine-Exposed Children With HIV Infection.
    Yogev R
    JAMA; 2015 Nov; 314(17):1801-2. PubMed ID: 26529157
    [No Abstract]   [Full Text] [Related]  

  • 37. Structured treatment interruption for patients with human immunodeficiency virus infection.
    Roca B
    N Engl J Med; 2003 Dec; 349(23):2268-9; author reply 2268-9. PubMed ID: 14657438
    [No Abstract]   [Full Text] [Related]  

  • 38. Timing of antiretroviral drugs during tuberculosis therapy.
    Kadhiravan T
    N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
    [No Abstract]   [Full Text] [Related]  

  • 39. Laboratory monitoring for antiretroviral therapy in low-resource settings.
    Boyer S; Laurent C; Kouanfack C; Delaporte E; Moatti JP
    Lancet Infect Dis; 2013 Sep; 13(9):739. PubMed ID: 23969214
    [No Abstract]   [Full Text] [Related]  

  • 40. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.